Literature DB >> 14617018

Endothelial cell activation in thrombotic thrombocytopenic purpura (TTP): a prospective analysis.

Thalia Romani De Wit1, Rob Fijnheer, Herm-Jan Brinkman, Sabina Kersting, Ronald J Hene, Jan A van Mourik.   

Abstract

It is generally assumed that endothelial cell injury is the primary event in the pathogenesis of thrombotic thrombocytopenic purpura (TTP). In this study, we have determined the extent of vascular perturbation during acute episodes of the disease. We performed a prospective, serial study of nine patients with relapsing TTP during hospitalization and treatment, and assessed the degree of endothelial cell involvement at admission, exacerbation and remission by measurement of von Willebrand factor (VWF) and VWF-propeptide levels. Measurement of both VWF and its propeptide enabled discrimination between acute and chronic perturbation of the endothelium. Elevated levels of both VWF and propeptide were found at admission. These levels decreased immediately upon plasma exchange therapy. However, plasma VWF and propeptide concentrations did not change, even at the time of acute exacerbation. These observations suggest that endothelial cell activation is not the primary event leading to TTP. Vascular perturbation seems to be a consequence, rather than a cause, of the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14617018     DOI: 10.1046/j.1365-2141.2003.04645.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

Review 1.  Is there a microangiopathic antiphospholipid syndrome?

Authors:  Ronald A Asherson; Sylvia S Pierangeli; Ricard Cervera
Journal:  Ann Rheum Dis       Date:  2007-04       Impact factor: 19.103

2.  Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c.

Authors:  J A McClung; N Naseer; M Saleem; G P Rossi; M B Weiss; N G Abraham; A Kappas
Journal:  Diabetologia       Date:  2005-01-20       Impact factor: 10.122

Review 3.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

Review 4.  Mechanisms of microvascular thrombosis in thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Kidney Int Suppl       Date:  2009-02       Impact factor: 10.545

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.